Global Antiprotozoal Drugs Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Antiprotozoal Drugs market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Sanofi
Mission Pharmacal
Immuron Ltd
Akthelia Pharmaceuticals Ltd
Dr. Reddy’s Laboratories
GlaxoSmithKline Plc
Mylan Pharmaceuticals
Protein Potential LLC
Microbiotix Inc
Aceto Corp.
Sun Pharmaceutical
Johnson & Johnson
Impax Laboratories
Profounda
Heritage Pharmaceuticals
Glenmark Pharmaceuticals
Pfizer
Bristol-Myers Squibb
Gilead Sciences
Lupin Pharmaceuticals
Pude Pharmaceutica
Knight Therapeutics
Guilin Pharmaceuticals
KPC Pharmaceuticals
Fangsheng
Albert David
Wanlong
By Types:
Amoebic Dysentery
Antimalarial Drug
Leishmaniasis & Chagas Disease
By Applications:
Hospital
Clinic
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview
1.1 Study Scope and Definition
1.2 Research Methodology
1.2.1 Methodology/Research Approach
1.2.2 Data Source
1.3 Key Market Segments
1.4 Players Covered: Ranking by Antiprotozoal Drugs Revenue
1.5 Market Analysis by Type
1.5.1 Global Antiprotozoal Drugs Market Size Growth Rate by Type: 2021 VS 2027
1.5.2 Amoebic Dysentery
1.5.3 Antimalarial Drug
1.5.4 Leishmaniasis & Chagas Disease
1.6 Market by Application
1.6.1 Global Antiprotozoal Drugs Market Share by Application: 2022-2027
1.6.2 Hospital
1.6.3 Clinic
1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections
1.7.2 Covid-19 Impact: Commodity Prices Indices
1.7.3 Covid-19 Impact: Global Major Government Policy
1.8 Study Objectives
1.9 Years Considered
2 Global Antiprotozoal Drugs Market Trends and Growth Strategy
2.1 Market Top Trends
2.2 Market Drivers
2.3 Market Challenges
2.4 Porter’s Five Forces Analysis
2.5 Market Growth Strategy
2.6 SWOT Analysis
3 Global Antiprotozoal Drugs Market Players Profiles
3.1 Sanofi
3.1.1 Sanofi Company Profile
3.1.2 Sanofi Antiprotozoal Drugs Product Specification
3.1.3 Sanofi Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.2 Mission Pharmacal
3.2.1 Mission Pharmacal Company Profile
3.2.2 Mission Pharmacal Antiprotozoal Drugs Product Specification
3.2.3 Mission Pharmacal Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.3 Immuron Ltd
3.3.1 Immuron Ltd Company Profile
3.3.2 Immuron Ltd Antiprotozoal Drugs Product Specification
3.3.3 Immuron Ltd Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 Akthelia Pharmaceuticals Ltd
3.4.1 Akthelia Pharmaceuticals Ltd Company Profile
3.4.2 Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Product Specification
3.4.3 Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Dr. Reddy’s Laboratories
3.5.1 Dr. Reddy’s Laboratories Company Profile
3.5.2 Dr. Reddy’s Laboratories Antiprotozoal Drugs Product Specification
3.5.3 Dr. Reddy’s Laboratories Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 GlaxoSmithKline Plc
3.6.1 GlaxoSmithKline Plc Company Profile
3.6.2 GlaxoSmithKline Plc Antiprotozoal Drugs Product Specification
3.6.3 GlaxoSmithKline Plc Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Mylan Pharmaceuticals
3.7.1 Mylan Pharmaceuticals Company Profile
3.7.2 Mylan Pharmaceuticals Antiprotozoal Drugs Product Specification
3.7.3 Mylan Pharmaceuticals Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Protein Potential LLC
3.8.1 Protein Potential LLC Company Profile
3.8.2 Protein Potential LLC Antiprotozoal Drugs Product Specification
3.8.3 Protein Potential LLC Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Microbiotix Inc
3.9.1 Microbiotix Inc Company Profile
3.9.2 Microbiotix Inc Antiprotozoal Drugs Product Specification
3.9.3 Microbiotix Inc Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Aceto Corp.
3.10.1 Aceto Corp. Company Profile
3.10.2 Aceto Corp. Antiprotozoal Drugs Product Specification
3.10.3 Aceto Corp. Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 Sun Pharmaceutical
3.11.1 Sun Pharmaceutical Company Profile
3.11.2 Sun Pharmaceutical Antiprotozoal Drugs Product Specification
3.11.3 Sun Pharmaceutical Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Johnson & Johnson
3.12.1 Johnson & Johnson Company Profile
3.12.2 Johnson & Johnson Antiprotozoal Drugs Product Specification
3.12.3 Johnson & Johnson Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.13 Impax Laboratories
3.13.1 Impax Laboratories Company Profile
3.13.2 Impax Laboratories Antiprotozoal Drugs Product Specification
3.13.3 Impax Laboratories Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.14 Profounda
3.14.1 Profounda Company Profile
3.14.2 Profounda Antiprotozoal Drugs Product Specification
3.14.3 Profounda Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.15 Heritage Pharmaceuticals
3.15.1 Heritage Pharmaceuticals Company Profile
3.15.2 Heritage Pharmaceuticals Antiprotozoal Drugs Product Specification
3.15.3 Heritage Pharmaceuticals Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.16 Glenmark Pharmaceuticals
3.16.1 Glenmark Pharmaceuticals Company Profile
3.16.2 Glenmark Pharmaceuticals Antiprotozoal Drugs Product Specification
3.16.3 Glenmark Pharmaceuticals Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.17 Pfizer
3.17.1 Pfizer Company Profile
3.17.2 Pfizer Antiprotozoal Drugs Product Specification
3.17.3 Pfizer Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.18 Bristol-Myers Squibb
3.18.1 Bristol-Myers Squibb Company Profile
3.18.2 Bristol-Myers Squibb Antiprotozoal Drugs Product Specification
3.18.3 Bristol-Myers Squibb Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.19 Gilead Sciences
3.19.1 Gilead Sciences Company Profile
3.19.2 Gilead Sciences Antiprotozoal Drugs Product Specification
3.19.3 Gilead Sciences Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.20 Lupin Pharmaceuticals
3.20.1 Lupin Pharmaceuticals Company Profile
3.20.2 Lupin Pharmaceuticals Antiprotozoal Drugs Product Specification
3.20.3 Lupin Pharmaceuticals Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.21 Pude Pharmaceutica
3.21.1 Pude Pharmaceutica Company Profile
3.21.2 Pude Pharmaceutica Antiprotozoal Drugs Product Specification
3.21.3 Pude Pharmaceutica Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.22 Knight Therapeutics
3.22.1 Knight Therapeutics Company Profile
3.22.2 Knight Therapeutics Antiprotozoal Drugs Product Specification
3.22.3 Knight Therapeutics Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.23 Guilin Pharmaceuticals
3.23.1 Guilin Pharmaceuticals Company Profile
3.23.2 Guilin Pharmaceuticals Antiprotozoal Drugs Product Specification
3.23.3 Guilin Pharmaceuticals Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.24 KPC Pharmaceuticals
3.24.1 KPC Pharmaceuticals Company Profile
3.24.2 KPC Pharmaceuticals Antiprotozoal Drugs Product Specification
3.24.3 KPC Pharmaceuticals Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.25 Fangsheng
3.25.1 Fangsheng Company Profile
3.25.2 Fangsheng Antiprotozoal Drugs Product Specification
3.25.3 Fangsheng Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.26 Albert David
3.26.1 Albert David Company Profile
3.26.2 Albert David Antiprotozoal Drugs Product Specification
3.26.3 Albert David Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.27 Wanlong
3.27.1 Wanlong Company Profile
3.27.2 Wanlong Antiprotozoal Drugs Product Specification
3.27.3 Wanlong Antiprotozoal Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
4 Global Antiprotozoal Drugs Market Competition by Market Players
4.1 Global Antiprotozoal Drugs Production Capacity Market Share by Market Players (2016-2021)
4.2 Global Antiprotozoal Drugs Revenue Market Share by Market Players (2016-2021)
4.3 Global Antiprotozoal Drugs Average Price by Market Players (2016-2021)
5 Global Antiprotozoal Drugs Production by Regions (2016-2021)
5.1 North America
5.1.1 North America Antiprotozoal Drugs Market Size (2016-2021)
5.1.2 Antiprotozoal Drugs Key Players in North America (2016-2021)
5.1.3 North America Antiprotozoal Drugs Market Size by Type (2016-2021)
5.1.4 North America Antiprotozoal Drugs Market Size by Application (2016-2021)
5.2 East Asia
5.2.1 East Asia Antiprotozoal Drugs Market Size (2016-2021)
5.2.2 Antiprotozoal Drugs Key Players in East Asia (2016-2021)
5.2.3 East Asia Antiprotozoal Drugs Market Size by Type (2016-2021)
5.2.4 East Asia Antiprotozoal Drugs Market Size by Application (2016-2021)
5.3 Europe
5.3.1 Europe Antiprotozoal Drugs Market Size (2016-2021)
5.3.2 Antiprotozoal Drugs Key Players in Europe (2016-2021)
5.3.3 Europe Antiprotozoal Drugs Market Size by Type (2016-2021)
5.3.4 Europe Antiprotozoal Drugs Market Size by Application (2016-2021)
5.4 South Asia
5.4.1 South Asia Antiprotozoal Drugs Market Size (2016-2021)
5.4.2 Antiprotozoal Drugs Key Players in South Asia (2016-2021)
5.4.3 South Asia Antiprotozoal Drugs Market Size by Type (2016-2021)
5.4.4 South Asia Antiprotozoal Drugs Market Size by Application (2016-2021)
5.5 Southeast Asia
5.5.1 Southeast Asia Antiprotozoal Drugs Market Size (2016-2021)
5.5.2 Antiprotozoal Drugs Key Players in Southeast Asia (2016-2021)
5.5.3 Southeast Asia Antiprotozoal Drugs Market Size by Type (2016-2021)
5.5.4 Southeast Asia Antiprotozoal Drugs Market Size by Application (2016-2021)
5.6 Middle East
5.6.1 Middle East Antiprotozoal Drugs Market Size (2016-2021)
5.6.2 Antiprotozoal Drugs Key Players in Middle East (2016-2021)
5.6.3 Middle East Antiprotozoal Drugs Market Size by Type (2016-2021)
5.6.4 Middle East Antiprotozoal Drugs Market Size by Application (2016-2021)
5.7 Africa
5.7.1 Africa Antiprotozoal Drugs Market Size (2016-2021)
5.7.2 Antiprotozoal Drugs Key Players in Africa (2016-2021)
5.7.3 Africa Antiprotozoal Drugs Market Size by Type (2016-2021)
5.7.4 Africa Antiprotozoal Drugs Market Size by Application (2016-2021)
5.8 Oceania
5.8.1 Oceania Antiprotozoal Drugs Market Size (2016-2021)
5.8.2 Antiprotozoal Drugs Key Players in Oceania (2016-2021)
5.8.3 Oceania Antiprotozoal Drugs Market Size by Type (2016-2021)
5.8.4 Oceania Antiprotozoal Drugs Market Size by Application (2016-2021)
5.9 South America
5.9.1 South America Antiprotozoal Drugs Market Size (2016-2021)
5.9.2 Antiprotozoal Drugs Key Players in South America (2016-2021)
5.9.3 South America Antiprotozoal Drugs Market Size by Type (2016-2021)
5.9.4 South America Antiprotozoal Drugs Market Size by Application (2016-2021)
5.10 Rest of the World
5.10.1 Rest of the World Antiprotozoal Drugs Market Size (2016-2021)
5.10.2 Antiprotozoal Drugs Key Players in Rest of the World (2016-2021)
5.10.3 Rest of the World Antiprotozoal Drugs Market Size by Type (2016-2021)
5.10.4 Rest of the World Antiprotozoal Drugs Market Size by Application (2016-2021)
6 Global Antiprotozoal Drugs Consumption by Region (2016-2021)
6.1 North America
6.1.1 North America Antiprotozoal Drugs Consumption by Countries
6.1.2 United States
6.1.3 Canada
6.1.4 Mexico
6.2 East Asia
6.2.1 East Asia Antiprotozoal Drugs Consumption by Countries
6.2.2 China
6.2.3 Japan
6.2.4 South Korea
6.3 Europe
6.3.1 Europe Antiprotozoal Drugs Consumption by Countries
6.3.2 Germany
6.3.3 United Kingdom
6.3.4 France
6.3.5 Italy
6.3.6 Russia
6.3.7 Spain
6.3.8 Netherlands
6.3.9 Switzerland
6.3.10 Poland
6.4 South Asia
6.4.1 South Asia Antiprotozoal Drugs Consumption by Countries
6.4.2 India
6.5 Southeast Asia
6.5.1 Southeast Asia Antiprotozoal Drugs Consumption by Countries
6.5.2 Indonesia
6.5.3 Thailand
6.5.4 Singapore
6.5.5 Malaysia
6.5.6 Philippines
6.6 Middle East
6.6.1 Middle East Antiprotozoal Drugs Consumption by Countries
6.6.2 Turkey
6.6.3 Saudi Arabia
6.6.4 Iran
6.6.5 United Arab Emirates
6.7 Africa
6.7.1 Africa Antiprotozoal Drugs Consumption by Countries
6.7.2 Nigeria
6.7.3 South Africa
6.8 Oceania
6.8.1 Oceania Antiprotozoal Drugs Consumption by Countries
6.8.2 Australia
6.9 South America
6.9.1 South America Antiprotozoal Drugs Consumption by Countries
6.9.2 Brazil
6.9.3 Argentina
6.10 Rest of the World
6.10.1 Rest of the World Antiprotozoal Drugs Consumption by Countries
7 Global Antiprotozoal Drugs Production Forecast by Regions (2022-2027)
7.1 Global Forecasted Production of Antiprotozoal Drugs (2022-2027)
7.2 Global Forecasted Revenue of Antiprotozoal Drugs (2022-2027)
7.3 Global Forecasted Price of Antiprotozoal Drugs (2022-2027)
7.4 Global Forecasted Production of Antiprotozoal Drugs by Region (2022-2027)
7.4.1 North America Antiprotozoal Drugs Production, Revenue Forecast (2022-2027)
7.4.2 East Asia Antiprotozoal Drugs Production, Revenue Forecast (2022-2027)
7.4.3 Europe Antiprotozoal Drugs Production, Revenue Forecast (2022-2027)
7.4.4 South Asia Antiprotozoal Drugs Production, Revenue Forecast (2022-2027)
7.4.5 Southeast Asia Antiprotozoal Drugs Production, Revenue Forecast (2022-2027)
7.4.6 Middle East Antiprotozoal Drugs Production, Revenue Forecast (2022-2027)
7.4.7 Africa Antiprotozoal Drugs Production, Revenue Forecast (2022-2027)
7.4.8 Oceania Antiprotozoal Drugs Production, Revenue Forecast (2022-2027)
7.4.9 South America Antiprotozoal Drugs Production, Revenue Forecast (2022-2027)
7.4.10 Rest of the World Antiprotozoal Drugs Production, Revenue Forecast (2022-2027)
7.5 Forecast by Type and by Application (2022-2027)
7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
7.5.2 Global Forecasted Consumption of Antiprotozoal Drugs by Application (2022-2027)
8 Global Antiprotozoal Drugs Consumption Forecast by Regions (2022-2027)
8.1 North America Forecasted Consumption of Antiprotozoal Drugs by Country
8.2 East Asia Market Forecasted Consumption of Antiprotozoal Drugs by Country
8.3 Europe Market Forecasted Consumption of Antiprotozoal Drugs by Countriy
8.4 South Asia Forecasted Consumption of Antiprotozoal Drugs by Country
8.5 Southeast Asia Forecasted Consumption of Antiprotozoal Drugs by Country
8.6 Middle East Forecasted Consumption of Antiprotozoal Drugs by Country
8.7 Africa Forecasted Consumption of Antiprotozoal Drugs by Country
8.8 Oceania Forecasted Consumption of Antiprotozoal Drugs by Country
8.9 South America Forecasted Consumption of Antiprotozoal Drugs by Country
8.10 Rest of the world Forecasted Consumption of Antiprotozoal Drugs by Country
9 Global Antiprotozoal Drugs Sales by Type (2016-2027)
9.1 Global Antiprotozoal Drugs Historic Market Size by Type (2016-2021)
9.2 Global Antiprotozoal Drugs Forecasted Market Size by Type (2022-2027)
10 Global Antiprotozoal Drugs Consumption by Application (2016-2027)
10.1 Global Antiprotozoal Drugs Historic Market Size by Application (2016-2021)
10.2 Global Antiprotozoal Drugs Forecasted Market Size by Application (2022-2027)
11 Global Antiprotozoal Drugs Manufacturing Cost Analysis
11.1 Antiprotozoal Drugs Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.3 Manufacturing Process Analysis of Antiprotozoal Drugs
12 Global Antiprotozoal Drugs Marketing Channel, Distributors, Customers and Supply Chain
12.1 Marketing Channel
12.2 Antiprotozoal Drugs Distributors List
12.3 Antiprotozoal Drugs Customers
12.4 Antiprotozoal Drugs Supply Chain Analysis
13 Analyst's Viewpoints/Conclusions
14 Disclaimer
Research Methodology:
Antiprotozoal Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|